Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107501853 | 10750185 | 3 | F | 20140103 | 20160822 | 20150129 | 20160830 | EXP | UG-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-004640 | BRISTOL MYERS SQUIBB | 41.00 | YR | M | Y | 73.00000 | KG | 20160830 | OT | UG | UG |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107501853 | 10750185 | 1 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Oral | 50 MG, QD | 13150 | MG | Y | 0 | 50 | MG | QD | ||||
| 107501853 | 10750185 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Oral | 100 MG, QD | 13150 | MG | Y | 0 | 100 | MG | QD | ||||
| 107501853 | 10750185 | 3 | PS | EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | EFAVIRENZEMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1100 MG, QD | Y | 21937 | 1100 | MG | FILM-COATED TABLET | QD | |||||
| 107501853 | 10750185 | 4 | C | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | U | 0 | ||||||||||
| 107501853 | 10750185 | 5 | C | CEFTRIAXONE. | CEFTRIAXONE | 1 | Unknown | U | 0 | ||||||||||
| 107501853 | 10750185 | 6 | C | PACLITAXEL. | PACLITAXEL | 1 | Unknown | UNK | U | 0 | |||||||||
| 107501853 | 10750185 | 7 | C | DEXAMETHAZONE | DEXAMETHASONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 107501853 | 10750185 | 8 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 107501853 | 10750185 | 9 | C | SULFAMETHOXAZOLE-TRIMETHOPRIM (SMZ) | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107501853 | 10750185 | 1 | Antiretroviral therapy |
| 107501853 | 10750185 | 3 | Antiretroviral therapy |
| 107501853 | 10750185 | 4 | Prophylaxis |
| 107501853 | 10750185 | 5 | Product used for unknown indication |
| 107501853 | 10750185 | 6 | Product used for unknown indication |
| 107501853 | 10750185 | 7 | Product used for unknown indication |
| 107501853 | 10750185 | 8 | Product used for unknown indication |
| 107501853 | 10750185 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107501853 | 10750185 | OT |
| 107501853 | 10750185 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107501853 | 10750185 | Acute kidney injury | |
| 107501853 | 10750185 | Anaemia | |
| 107501853 | 10750185 | Bacteraemia | |
| 107501853 | 10750185 | Disease progression | |
| 107501853 | 10750185 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107501853 | 10750185 | 1 | 20130725 | 20131106 | 0 | |
| 107501853 | 10750185 | 2 | 20130820 | 20131106 | 0 | |
| 107501853 | 10750185 | 3 | 20130724 | 0 | ||
| 107501853 | 10750185 | 6 | 20140508 | 0 | ||
| 107501853 | 10750185 | 7 | 20140508 | 0 | ||
| 107501853 | 10750185 | 8 | 20140508 | 0 |